'Compliance' is futile but is 'concordance' between rheumatology patients and health professionals attainable?

Rheumatology

Volumn 45, Issue 1, 2006, Pages 1-5

  Treharne, G J ^a,b   Lyons, A C ^c   Hale, E D ^b   Douglas, K M J ^b   Kitas, G D ^a,b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b DUDLEY GROUP OF HOSPITALS NHS TRUST   (United Kingdom)

^c MASSEY UNIVERSITY   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; SALAZOSULFAPYRIDINE; STEROID; TUMOR NECROSIS FACTOR ANTIBODY;

ANALGESIA; DOCTOR PATIENT RELATION; DRUG MONITORING; DRUG SAFETY; EDITORIAL; FOLLOW UP; HEALTH BEHAVIOR; HUMAN; INFECTION; MEDICAL DECISION MAKING; PATIENT AUTONOMY; PATIENT COMPLIANCE; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; RHEUMATOLOGY; SELF CONCEPT; SOCIAL PSYCHOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT PLANNING;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIRHEUMATIC AGENTS; HUMANS; PATIENT COMPLIANCE; PROFESSIONAL-PATIENT RELATIONS; RHEUMATIC DISEASES;

EID: 29844438167     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kei223     Document Type: Editorial

References (68)

1. Sackett DL, Snow JC. The magnitude of compliance and non-compliance. In: Haynes RB, Taylor WD, Sackett DL, eds' Compliance in Health Care. Baltimore, MD: Johns Hopkins University Press, 1979:11-32.
2. DiMatteo MR. Variations in patients' adherence to medical recommendations: A quantitative review of 50 years of research. Med Care 2004;42:200-9.
3. Elliott RA, Barber N, Horne R. Cost-effectiveness of adherence-enhancing interventions: A quality assessment of the evidence. Ann Pharmacother 2005;39:508-15.
4. McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions: Scientific review. J Am Med Assoc 2002;288:2868-79.
5. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005;353:487-97.
6. Vermeire E, Hearnshaw H, Van Royen P, Denekens J. Patient adherence to treatment: Three decades of research. A comprehensive review. J Clin Pharm Ther 2001;26:331-42.
7. Kitas GD, Erb N. Tackling ischaemic heart disease in rheumatoid arthritis. Rheumatology 2003;42:607-13.
8. Woolf SH, Chart EC, Harris R et al. Promoting informed choice: transforming health care to dispense knowledge for decision making. Ann Intern Med 2005;143:293-300.
9. Charavel M, Bremond A, Moumjid-Ferdjaoui N, Mignotte H, Carrere MO. Shared decision-making in question. Psycho-Oncology 2001;10:93-102.
10. The Oxford English Dictionary. Comply, v.1. OED Online, 2nd edn. Oxford: Oxford University Press, 1989. Available at: http://dictionary.oed.com/cgi/entry/50045736. Accessed 14 October 2005.
11. The Oxford English Dictionary. Adhere, v. OED Online, 2nd edn. Oxford: Oxford University Press, 1989. Available at: http://dictionary.oed.com/cgi/entry/50002620. Accessed 14 October 2005.
12. The Oxford English Dictionary. Adherence. OED Online, 2nd edn. Oxford: Oxford University Press, 1989. Available at: http://dictionary.oed.com/cgi/entry/50002621. Accessed 14 October 2005.
13. Barber N, Parsons J, Clifford S, Darracott R, Horne R. Patients' problems with new medication for chronic conditions. Qual Saf Health Care 2004;13:172-5.
14. Berry D, Bradlow A, Bersellini E. Perceptions of the risks and benefits of medicines in patients with rheumatoid arthritis and other painful musculoskeletal conditions. Rheumatology 2004; 43:901-5.
15. Petri M, Perez-Gutthann S, Longenecker JC, Hochberg M. Morbidity of systemic lupus erythematosus: Role of race and socioeconomic status. Am J Med 1991;91:345-53.
16. Mosley-Williams A, Lumley MA, Gillis M, Leisen J, Guice D. Barriers to treatment adherence among African American and white women with systemic lupus erythematosus. Arthritis Care Res 2002; 47:630-8.
17. McElhone K, Teh L-S, Walker J, Abbott J. Treatment adherence in systemic lupus erythematosus (SLE). Rheumatology 2005;44(Suppl.):i141.
18. Recker RR, Gallagher R, MacCosbe PE. Effect of dosing frequency on bisphosphonate medication adherence in a large longitudinal cohort of women. Mayo Clin Proc 2005;80:856-61.
19. Neame R, Hammond A. Beliefs about medications: A questionnaire survey of people with rheumatoid arthritis. Rheumatology 2005; 44:762-7.
20. Viller F, Guillemin F, Briançon S, Moum T, Suurmeijer T, van den Heuvel W. Compliance to drug treatment of patients with rheumatoid arthritis: A 3 year longitudinal study. J Rheumatol 1999;26:2114-22.
21. Park DC, Hertzog C, Leventhal H et al. Medication adherence in rheumatoid arthritis patients: Older is wiser. J Am Geriatr Soc 1999;47:172-83.
22. de Klerk E, van der Heijde D, Landewé R, van der Tempel H, Urquhart J, van der Linden S. Patient compliance in rheumatoid arthritis, polymyalgia rheumatica, and gout. J Rheumatol 2003; 30:44-54.
23. Bannwarth B. Do selective cyclo-oxygenase-2 inhibitors have a future? Drug Saf 2005;28:183-9.
24. Treharne GJ, Lyons AC, Kitas GD. Medication adherence in rheumatoid arthritis: Effects of psychosocial factors. Psychol Health Med 2004;9:337-49.
25. Schwartzman S, Morgan GJ Jr. Does route of administration affect the outcome of TNF antagonist therapy? Arthritis Res Ther 2004; 6:S19-S23.
26. Antivalle M, Mutti A, Marrazza M et al. Patient preferences and compliance during rheumatoid arthritis treatment with tumor necrosis factor antagonists. Ann Rheum Dis 2005; 64(Suppl.):222.
27. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986;24:67-74.
28. Sewitch MJ, Dobkin PJ, Bernatsky S et al. Medication non-adherence in women with fibromyalgia. Rheumatology 2004;43: 648-54.
29. Butler JA, Peveler RC, Roderick PJ, Horne R, Mason JC. Measuring compliance to drug regimes following renal transplantation: A comparison of self-report and clinician rating with electronic monitoring. Transplantation 2004;77:786-9.
30. de Klerk E, van der Heijde D, van der Tempel H, van der Linden S. Development of a questionnaire to investigate patient compliance with antirheumatic drug therapy. J Rheumatol 1999;26:2635-41.
31. de Klerk E, van der Heijde D, Landewé R, van der Tempel H, van der Linden S. The compliance-questionnaire-rheumatology compared with electronic medication event monitoring: A validation study. J Rheumatol 2003;30:2469-75.
32. Treharne GJ, Lyons AC, Hale ED, Douglas KMJ, Kitas GD. Predictors of medication adherence in people with rheumatoid arthritis: Studies are necessary but non-validated measures of medication adherence are of concern. Rheumatology 2005;44:1330.
33. Horne R, Weinman J, Hankins M. The Beliefs about Medicines Questionnaire: The development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health 1999;14:1-24.
34. Horne R, Graupner L, Frost S, Weinman J, Wright SM, Hankins M. Medicine in a multi-cultural society: The effect of cultural background on beliefs about medications. Soc Sci Med 2004;59:1307-13.
35. Goodacre LJ, Goodacre JA. Factors influencing the beliefs of patients with rheumatoid arthritis regarding disease-modifying medication. Rheumatology 2004;43:583-6.
36. Riekert KA, Drotar D. The Beliefs About Medication Scale: Development, reliability, and validity. J Clin Psychol Med S 2002; 9:177-84.
37. Blalock SJ, Patel RA. Drug therapy concerns questionnaire: Initial development and refinement. J Am Pharm Assoc 2005;45:160-9.
38. Hill J, Bird H, Dimmock S. The effect of patient education on adherence to drug therapy for rheumatoid arthritis: A randomised controlled trial. Ann Rheum Dis 2001;60:869-75.
39. Higgins N, Livingston G, Katona C. Concordance therapy: An intervention to help older people take antidepressants. J Affect Disord 2004;81:287-91.
40. Kennedy T, McCabe C, Struthers G et al. BSR guidelines on standards of care for persons with rheumatoid arthritis. Rheumatology 2005;44:553-6.
41. The Oxford English Dictionary. Concord, n.1. OED Online. 2nd ed. Oxford: Oxford University Press, 1989. Available at: http://dictionary.oed.com/cgi/entry/50046417. Accessed 14 October 2005.
42. Marinker M, Blenkinsopp A, Bond C et al. From Compliance to Concordance: Achieving Shared Goals in Medicine Taking. London: Royal Pharmaceutical Society of Great Britain, 1997. Available at: http://www.medicines-partnership.org/about-us/history-context. Accessed 14 October 2005.
43. Task Force on Medicines Partnership. Year 1 Annual Report 2002. London: Medicines Partnership, 2003. Available at: http://www.medicines-partnership.org/about-us/annual-report. Accessed 14 October 2005.
44. Ong BN, Hooper H. Comparing clinical and lay accounts of the diagnosis and treatment of back pain. Sociol Health Illn: In press.
45. Kiely PDW. Symptom concealment: A new phenomenon in patients treated with biological therapies? Rheumatology 2004;43:114-5.
46. Frosch DL, Kaplan RM. Shared decision making in clinical medicine: Past research and future directions. Am J Prev Med 1999;17:285-94.
47. Whitney SN. A new model of medical decisions: Exploring the limits of shared decision making. Med Decis Making 2003;23:275-80.
48. National Institute for Clinical Excellence. Technology Appraisal Guidance, No. 36: Guidance on the use of etanercept and infliximab for the treatment of rheumatoid arthritis. London: National Institute for Clinical Excellence, 2002. Available at: http://www.nice.org.uk/pdf/RA-PDF.pdf. Accessed 14 October 2005.
49. Lim AYN, Ellis C, Brooksby A, Gaffney K. Concordance with DMARDs and biologics. Rheumatology 2005;44(Suppl.):i153.
50. Neame R, Hammond A, Deighton C. Need for information and for involvement in decision making among patients with rheumatoid arthritis: A questionnaire survey. Arthritis Care Res 2005;53:249-55.
51. Ryan S, Hassell A, Dawes P, Kendall S. Control perceptions in patients with rheumatoid arthritis: The impact of the medical consultation. Rheumatology 2003;42:135-40.
52. Kirby J. Concordance: New idea, old problem. Arthritis News 2003; 5:22-4.
53. Stiggelbout AM, Molewijk AC, Otten W, Timmermans DRM, van Bockel JH, Kievit J. Ideals of patient autonomy in clinical decision making: A study on the development of a scale to assess patients' and physicians' views. J Med Ethics 2004;30:268-74.
54. Doherty C, Doherty W. Patients' preferences for involvement in clinical decision-making within secondary care and the factors that influence their preferences. J Nurs Manag 2005;13:119-27.
55. Woolhead GM, Donovan JL, Chard JA, Dieppe PA. Who should have priority for a knee joint replacement? Rheumatology 2002; 41:390-4.
56. Donovan JL, Blake DR. Patient non-compliance: Deviance or reasoned decision-making? Soc Sci Med 1992;34:507-13.
57. Raynor DK, Thistlethwaite JE, Hart K, Knapp P. Are health professionals ready for the new philosophy of concordance in medicine taking? Int J Pharm Pract 2001;9:81-4.
58. Stokes M, Knapp P, Thistlethwaite JE, Raynor DK. Using the LATCon scale to measure patients' attitudes to concordance. Proceedings of the Health Services Research & Pharmacy Practice Conference. Available at: http://www.hsrpp.org.uk/abstracts/2002_18.shtml. Accessed 14 October 2005.
59. Bradley E, Campbell P, Nolan P. Nurse prescribers: Who are they and how do they perceive their role? J Adv Nurs 2005;51:439-48.
60. Expert Patient Programme. What is an expert patient? 2005. Available at: http://www.expertpatients.nhs.uk/what.shtml. Accessed 14 October 2005.
61. Thistlethwaite JE, Raynor DK, Knapp P. Medical students' attitudes towards concordance in medicine taking: Exploring the impact of an educational intervention. Educ Health 2003; 16:307-17.
62. Department of Health. Involving patients and the public in healthcare: A discussion document. London: Department of Health, 2001. Available at: http://www.dh.gov.uk/assetRoot/04/07/98/41/04079841.pdf. Accessed 14 October 2005.
63. Feldman S, Behnam SM, Behnam SE, Koo JY. Involving the patient: Impact of inflammatory skin disease and patient-focused care. J Am Acad Dermatol 2005;53:S78-S85.
64. Leong AL, Euller-Ziegler L. Patient advocacy and arthritis: Moving forward. Bull World Health Organ 2004;82:115-20.
65. Horne R. Treatment perceptions and self-regulation. In: Cameron LD, Leventhal H, eds. The Self-Regulation of Health and Illness Behaviour. London: Routledge, 2003;138-53.
66. Bandura A. Self-efficacy: Towards a unifying theory of behavioural change. Psychol Rev 1977;84:191-215.
67. Lorig K, Chastain RL, Ung E, Shoor S, Holman HR. Development and evaluation of a scale to measure perceived self-efficacy in people with arthritis. Arthritis Rheum 1989;32:37-44.
68. Barlow JH, Williams B, Wright CC. The arthritis self-efficacy scale in a UK context. Psychol Health Med 1997;2:3-17.